Radiologia Brasileira - Publicação Científica Oficial do Colégio Brasileiro de Radiologia

INTRODUCTION

Flaviviruses are among the most important emerging viruses known to man, being transmitted by mosquitoes and ticks. The Zika virus (ZIKV) pandemic is the most recent of the arthropod-borne viral diseases, following on the heels of dengue, West Nile virus, and chikungunya, for which outbreaks were recorded in 1990, 1999, and 2013, respectively⁽¹⁾. ZIKV is an arbovirus of the family Flaviviridae, composed of ribonucleic acid, which was discovered in Uganda in 1947, although the first case in humans was not reported until 1952^(1-8). Typically, it occurs in tropical and subtropical areas of the world, mainly in Africa and Asia, the two major lineages (Asian and African) originating from a common ancestor^(1-8). Like other arboviruses, ZIKV presents many barriers to the accumulation of mutations, as a consequence of double replication in mammalian and invertebrate hosts, and the rate of fixation of its mutations is therefore relatively slow⁽⁵⁾.

Beginning in 2007, ZIKV, which had until then been confined to a narrow equatorial zone in Africa and Asia, began to become more widespread, affecting Micronesia; in the 2013–2014 period, there was a ZIKV epidemic in French Polynesia and New Caledonia. Since then, there has been a progressive expansion of the virus, cases of ZIKV infection having been reported in South America, Central America, and the Caribbean Islands^(1,4), the displacement of people and the presence of vectors being important factors for its dissemination.

The first autochthonous ZIKV transmission in Brazil occurred in May 2015^(4,8), with probable dissemination from the Pacific region, given that phylogenetic studies have shown high similarity (99.7% for nucleotides and 99.9% for amino acids) with the virus circulating among islands in the Pacific Ocean⁽²⁾. Brazil was the Latin American country most affected by ZIKV, approximately 1,500,000 cases being reported in 2015 and 2016⁽³⁾. Global warming and climate change, together with the El Niño phenomenon, might have contributed to accelerating the spread of the virus and its vector, additional factors including the low socioeconomic status and lack of awareness of the population, as evidenced by the fact that the epidemic was more intense in impoverished areas of the northern and northeastern regions of the country, especially in the states of Pernambuco, Bahia, and Paraíba⁽³⁾.

During epidemics, various forms of central nervous system (CNS) involvement associated with ZIKV infection have been reported, such as meningoencephalitis, Guillain-Barré syndrome, and acute disseminated encephalomyelitis^(2,3,5,7,9). Simultaneously, numerous cases of CNS malformations potentially related to congenital ZIKV infection, characterizing congenital Zika syndrome, have gained prominence in the scientific community, having been widely documented by computed tomography (CT) and magnetic resonance imaging (MRI).

Although the neuroimaging findings in congenital Zika syndrome are not pathognomonic, many are quite suggestive of the diagnosis, and radiologists should be prepared to recognize those findings, interpret them, and propose the diagnosis. The objective of this article is to review the CT and MRI findings in congenital Zika syndrome. To that end, we searched the PubMed database using the following search terms: “Zika virus”; “congenital Zika virus infection”; “zika neuroimaging”; “zika magnetic resonance imaging”; “zika computed tomography”; and “zika ultrasound”. We analyzed articles indexed up through May 2017.


ZIKV TRANSMISSION

The transmission of ZIKV occurs mainly by the bite of mosquitoes of the genus Aedes, which are common in the tropics and are also recognized vectors of dengue fever, yellow fever, and chikungunya. Although the main vector of ZIKV transmission is A. aegypti, other Aedes species, such as A. albopictus, A. africanus, A. luteocephalus, A. vittatus, A. furcifer, A. hensilli and A. apicoargenteus, can transmit the virus, as can mosquitoes of the genera Anopheles, Eretmapodites, Culex, and Mansonia^(1,3,5,8).

Aedes aegypti is widely distributed in the Americas, usually lives in close proximity to people and their homes, lays its eggs in still waters, as well as in water that collects in buckets, flowerpots, empty pipes, and other containers, and bites mainly during the daytime^(3,4,7,8).

The infection cycle begins when Aedes species ingest ZIKV-infected blood, which initiates a process of viral replication in the epithelial cells of the midgut and migration of the virus to the salivary glands of the mosquito; after 5–10 days, the mosquito is able to transmit the virus to healthy individuals^(3,4). Other forms of transmission, such as blood transfusion, sexual (oral, anal, or vaginal) transmission, vertical (transplacental or perinatal) transmission, and transmission via urine, have been described^(1,2,4,8). Because most patients infected with ZIKV are asymptomatic, there is an extremely high risk of blood donors acting as a source of transmission in endemic areas⁽⁸⁾. Other suspected routes of ZIKA transmission include monkey bite, organ transplantation, and hemodialysis⁽³⁾. In kidney transplantation, the risk of ZIKV infection should be considered if the donor is a resident of or is returning from an endemic area, given ZIKV can be detected in the urine of people infected for more than 30 days⁽³⁾. Despite the fact that the viral particle has been isolated in breast milk, there is as yet no evidence of transmission through breastfeeding, although that route of transmission has been described for other flaviviruses^(3,5,10).


CLINICAL ASPECTS OF ZIKV INFECTION

In 75–80% of cases, ZIKV infection is asymptomatic⁽³⁾. In symptomatic cases, after an incubation period that typically lasts for 3–12 days, the most common manifestation is a self-limiting profile—low-grade fever (37.8–38.5°C); headache; muscle aches; pain in the small joints of the hands and feet; non-purulent conjunctivitis; ocular pain; prostration; and pruritic maculopapular rash—similar to that of dengue, albeit milder and typically evolving to regression of the symptoms in 2–7 days^(1,3,4). Hematological and biochemical parameters are usually normal^(1,3). After the first infection, the person develops immunity and will not develop the disease if again exposed to the virus^(2-5).

Although severe and fatal forms of ZIKV are quite rare, cases of Guillain-Barré syndrome, meningoencephalitis, and acute disseminated encephalomyelitis have been reported^(1,2,8,9,11), such cases having been attributed to the high degree of tropism of ZIKV for the CNS⁽⁸⁾.


DIAGNOSIS

Fauci et al.⁽¹²⁾ reported that the diagnosis of ZIKV infection can be made mainly on the basis of the clinical findings. However, the authors stated that this is only applicable in areas in which there is a current ZIKV epidemic and other diseases with a similar clinical presentation, such as dengue and chikungunya, are not endemic.

The diagnosis of ZIKV can be confirmed through amplification of the viral genome by reverse transcriptase-polymerase chain reaction (RT-PCR) in samples of blood, saliva, urine, cerebrospinal fluid and amniotic fluid, although the RT-PCR procedure is expensive and subject to contamination. In addition, due to the kinetics of ZIKV viremia, the timing of the investigation depends on the material collected^(1,3,8): in blood and saliva, RT-PCR can be performed only up until the seventh day after the onset of symptoms; in urine, the virus can be detected for more than 30 days after the onset of symptoms; and, in male patients, the virus can be detected in semen within the first 3–8 weeks after the onset of symptoms. Serological tests for the detection of immunoglobulin M antibodies against ZIKV are usually conducted 4–5 days after the onset of symptoms, and those antibodies can remain detectable for an additional 2–3 months, as has been reported for other flaviviruses^(2-4,8).


TREATMENT

Because ZIKV infection is usually self-limiting, the treatment consists of increased fluid intake and rest. Pharmacological treatment should be restricted to symptom relief⁽³⁾.

There are as yet no vaccines or antiviral therapies for ZIKV infection. Therefore, preventive measures, focusing on vector eradication—such as reducing the number of water reservoirs available for oviposition and using insecticides—and on mosquito bite avoidance—such as the use of repellents—are fundamental as the best form of controlling the disease^(3,8). It is also recommended that to that travelers returning from endemic areas to nonendemic areas be advised to use repellents for a minimum of 14 days, in order to prevent local mosquitoes from getting the virus⁽³⁾. Patients with clinical signs of the disease and individuals returning from endemic areas should also be advised to use condoms or abstain from sex, especially if their partner is pregnant^(2,3). Some health authorities also recommend that women avoid becoming pregnant during ZIKV epidemics and that those who are pregnant or intending to become pregnant avoid traveling to endemic areas⁽³⁾. Pregnant women who are symptomatic should be tested for ZIKV by RT-PCR, as should those in whom there is evidence of microcephaly on ultrasound. In the latter cases, follow-up ultrasound examinations should be performed every 3–4 weeks⁽²⁾.

Recently, the vector control group of the World Health Organization discussed the use of genetically modified mosquitoes for the control of A. aegypti. By competing with wild A. aegypti males, the male OX513A mosquito was successful in controlling dengue in Brazil⁽²⁾.


CAUSALITY OF MALFORMATIONS AND CONGENITAL ZIKV INFECTION

The cautious approach to implicating ZIKV as a cause of birth defects is not surprising, given that the last epidemic of birth defects caused by an infectious pathogen (the rubella virus) occurred more than 50 years ago⁽¹³⁾. In addition, no flaviviruses have been definitively demonstrated to be a cause of birth defects in humans and there have been no reports of adverse pregnancy events during previous ZIKV outbreaks^(13,14).

Two methods have been used in order to identify potential teratogens: the identification of the combination of a rare exposure and presentation of a rare defect, as was the case for rubella virus, which was identified by an ophthalmologist after noticing a characteristic form of cataract in children born to mothers with rubella infection during pregnancy^(13,15); and the identification of a causal relationship, which can be achieved through the use of epidemiological studies, as in the case of valproic acid, which was identified as a teratogen after a case-control study demonstrated a 20-fold increase in the incidence of spina bifida when valproic acid was administered during the first trimester of pregnancy^(13,16). In 1994, Thomas Shepard, a pioneer in the field of teratology, proposed seven criteria, including those previously cited, to confirm teratogenicity⁽¹⁷⁾. According to the Shepard system, causality is established through a rare exposure-rare defect approach—when criteria 1, 3, and 4 (as defined below) are met—or through an epidemiological approach—when criteria 1, 2, and 3 (as defined below) are met⁽¹³⁾.

In the Shepard system, criterion 1 is exposure to a given agent at a critical time during the course of the pregnancy. Microcephaly and other brain abnormalities that have been observed in many infants are consistent with infection occurring in the first trimester or at the beginning of the second trimester of pregnancy. An analysis of the time to biochemical confirmation of ZIKV transmission in certain Brazilian states and of the increased incidence of microcephaly identified the first trimester of pregnancy as the critical period of ZIKV infection⁽¹⁸⁾.

Criterion 2 in the Shepard system is the existence of at least two high-quality epidemiological studies supporting the association. Data from Brazil and French Polynesia demonstrated temporal and geographic associations between ZIKV infection and the subsequent appearance of infants with congenital microcephaly^(18-30). In one of those studies, conducted during the outbreak in Brazil, 88 pregnant women with a skin rash were tested for ZIKV RNA. Of the 72 who tested positive, 42 underwent ultrasound. Among those 42 women, fetal abnormalities were observed in 12 (29%). The 16 women who tested negative did not present abnormalities on the ultrasound examination⁽²¹⁾. Although those studies provided important evidence of a causal relationship, they presented limitations, as cited by their authors^(18,19,21), including a lack of control for confounding factors and a relatively small number of cases. Therefore, criterion 2 is not strictly met.

Shepard system criterion 3 is a specific defect or syndrome occurring after exposure to a given teratogen. In fact, many fetuses and infants with congenital ZIKV infection have presented a characteristic appearance, including severe microcephaly, intracranial calcifications and other brain abnormalities, sometimes accompanied by ocular alterations, cutis verticis gyrata (excessive scalp skin), arthrogryposis, and talipes equinovarus (clubfoot), leading some authors to coin the term “congenital Zika syndrome” to describe the presentation^(22,23). In addition, cutis verticis gyrata is not a typical finding in other forms of microcephaly.

Criterion 4 in the Shepard system is an association between a rare exposure and the subsequent appearance of a rare defect, the rationale of which is that it is unlikely that two rare events will occur in conjunction, especially with the appropriate chronology to suggest causation. Microcephaly is a rare defect estimated to occur in 6 out of 10,000 live births in the United States⁽¹³⁾. Although exposure to ZIKV was not uncommon among women residing in Brazil during the outbreak, there were reports of adverse events in fetuses among female travelers who were in endemic areas for only a short time, constituting a rare exposure^(24,25). In one report, a European woman presented fever and a skin rash at the end of week 13 of gestation, while in the state of Rio Grande do Norte, in northeastern Brazil. Prior to that, the woman had undergone a number of ultrasound examinations, none of which had shown any abnormalities. However, ultrasound performed at 29 weeks of gestation revealed multiple cerebral malformations. The fetus was aborted, and an autopsy was conducted. All organs were examined, as were the placenta and umbilical cord. The findings included microcephaly, pachygyria/lissencephaly, and hydrocephalus, together with multifocal dystrophic calcifications in the cortex and subcortical white matter, as well as signs of local inflammation and placental calcifications. There were no relevant pathological abnormalities in the remaining organs, and RT-PCR of the brain tissue was positive only for ZIKV, no other flaviviruses being identified. The ZIKV strain identified bore a high (99.7%) resemblance to the Asian lineage identified in the outbreak that occurred in French Polynesia in 2013⁽²⁵⁾.

Shepard system criterion 5 is the finding of teratogenicity in animal models. Animal studies of ZIKV have demonstrated not only its neurotropism but also its teratogenic potential^(26-29).

Criterion 6 in the Shepard system is that the association makes biological sense. Such sense has clearly been demonstrated, given that other viral agents have similar effects, as well as the fact that studies have shown that ZIKV has a high degree of tropism for and a deleterious effect on fetal brain tissue^(24,25).

The criterion 7 in the Shepard system is used only for exposure to medications and chemicals. Therefore, it does not apply to exposure to infectious agents.

In view of the above, according to the Shepard system, there is strong evidence that ZIKV is a teratogen.


MANIFESTATIONS OF CONGENITAL ZIKV INFECTION

The effects of intrauterine ZIKV infection are more severe when they occur in the first or second trimesters of pregnancy, especially in the first trimester, ranging from fetal death to various congenital abnormalities, which include cutis verticis gyrata (of the scalp, neck, or both), low birth weight, polyhydramnios, anasarca, arthrogryposis, and hearing loss, as well as ocular and CNS malformations with craniofacial manifestations^(3,25,30-33).

Of all the congenital manifestations of ZIKV infection, the one that has had the greatest impact is microcephaly, which has been well documented, in Brazil and French Polynesia, and has been associated with the Asian lineage of the virus. During the ZIKV epidemic in Brazil (from March 2015 to February 2016), there was a 20-fold increase in the incidence of microcephaly in comparison with previous years⁽³⁾.

In the literature, there is no consensus regarding the definition of microcephaly. Microcephaly is a brain growth disorder in which the head circumference is smaller than that expected for age, gender, and race; the cut-off value can be the 3rd or 5th percentile or 2–3 standard deviations below the mean^(31-33). It can be caused by numerous conditions, including genetic disorders and infectious diseases (rubella, cytomegalovirus infection, toxoplasmosis, herpes virus infection, HIV infection), as well as exposure to alcohol, drugs, or other toxic substances present in the environment. Clinically, patients with microcephaly present severe neurological impairment, common symptoms being hypertonia, spasticity, and seizures^{(13,15-17,33,34)}.

The pathogenesis of ZIKV microcephaly is not fully understood, although it is believed to begin with placental infection. In the placental tissue of pregnant women infected with ZIKV, Noronha et al.⁽²⁹⁾ detected viral proteins in Hofbauer cells and some histiocytes in the intervillous spaces, suggesting that ZIKV damages the placental barrier, inducing chronic placentitis⁽²⁹⁾, as has also been documented in rats⁽²⁸⁾. As gestation progresses, the virus disseminates to the fetal brain, where it preferentially infects neuronal progenitor cells, decreasing their viability and impeding their growth, thus inhibiting cell proliferation, cell differentiation, and neuronal apoptosis, with consequent thinning of the cortex and macroscopic signs of microcephaly^(3,30). It has also been suggested that the placental inflammatory process can act in synergy with cerebral ZIKV infection in the genesis of brain malformations⁽³²⁾.

Despite the neurotropism of ZIKV, there have been no reports of microcephaly in infected children soon after birth. That is probably attributable to the low infective potential of ZIKV in developed neural cells^(3,32,33).


NEUROIMAGING FINDINGS IN CONGENITAL ZIKA SYNDROME

In CT and MRI studies of congenital Zika syndrome, the findings most commonly reported are a reduction in head circumference and a dramatic reduction in brain volume, both of which are indicative of microcephaly and are more common when the infection occurs in the first trimester of pregnancy, with a risk of 1–13%^(34-41). Microcephaly can be asymmetric. The condition is mild in 25% of cases and moderate-to-severe in 75%⁽³⁵⁾.

An uncommon appearance of the skull, a finding that is common in congenital Zika syndrome and uncommon in microcephaly of other causes, is characterized by a collapsed aspect of the skull cap, with overlapping sutures and prominent occipital bones, creating a “shelf” appearance, commonly accompanied by excessive, folded skin on the scalp (Figure 1). That presentation could be due, in part, to the continued growth of the skull and skin while the size of the brain regresses, or even, at some point, collapse of the skull, which previously had larger dimensions due to cerebral ventriculomegaly^(34-40). One unusual finding that occurs in some newborns and suggests the latter hypothesis is herniation of the orbital fat to the skull, which could be secondary to the abrupt deformation of the skull, rather than direct infection of the eye, as occurs in other congenital infections⁽³⁴⁾.




Abnormalities of cortical development are frequent findings, occurring in 94–100% of cases, commonly presenting as agyria-pachygyria (Figure 2), and probably varying according to the stage of cortical development in which the infection occurs^(34-43). The involvement is usually diffuse, predominantly occurring in the frontal, insular, and parietal lobes, with varying degrees of severity; it is frequently accompanied by wide sylvian and interhemispheric fissures, as well as by an increase in the extra-axial cerebrospinal fluid (CSF) space, the last being associated with a loss of brain volume and impaired CSF reabsorption^(34-43). Gray matter heterotopia is rare⁽³⁸⁾.




Calcifications are common in congenital Zika syndrome, occurring in 88–100% of patients; unlike classic infections (toxoplasmosis, rubella, cytomegalovirus, herpes simplex, HIV, and syphilis), in which calcifications are periventricular and cortical, ZIKV infection tends to involve the cortical-subcortical junction (Figure 3); one possible explanation is that ZIKV infection has a vascular component, given that other processes that mainly affect this region are associated with vascular alterations^(34-43). As illustrated in Figure 4, there are other sites that present calcifications in ZIKV infection^(34-40), which are, in descending order of frequency, the following: the basal nuclei and thalamus (in 29–65% of cases); the periventricular region (in 14–65%); the cortical region (in 14–24%); and the infratentorial region (in 4–18%). It is noteworthy that periventricular and cortical involvement are more common in newborns in whom there is a significant loss of brain parenchymal volume; therefore, the precise location of calcifications in such newborns is difficult to determine⁽³⁴⁾. According to Oliveira-Szejnfeld et al., infratentorial calcifications are present in more severe manifestations, being accompanied by brainstem malformation, aqueduct stenosis, and secondary hydrocephalus⁽³⁴⁾.




There are inherent differences between CT and MRI, the former presenting greater sensitivity in the detection of calcifications even when compared with susceptibility-weighted MRI sequences, whereas MRI presents a greater capacity for characterizing cortical abnormalities and the development of the corpus callosum^(34-40).

Enlargement of the lateral ventricles, as depicted in Figure 5, is common, occurring in 94–100% of cases; in most cases, it is moderate-to-pronounced and symmetric; it is accompanied by septations in 10–29% of cases, and occipital horns are commonly seen, sometimes making it difficult to distinguish periventricular cysts^(34-43). It should also be borne in mind that the presence of ventriculomegaly is directly related to a reduction in brain volume and can cause the head circumference to remain normal or even increase^(34-40,43).




Hypoplasia, dysgenesis, and agenesis of the corpus callosum are often seen in congenital Zika syndrome (Figure 6), reportedly occurring in 75–94% of cases and presenting a direct correlation with parenchymal damage^(34-43). Other associated abnormalities are hippocampal malformation and thickening of the fornix^(34-40).




Brainstem abnormalities, which have been reported in 21–70% of patients with congenital ZIKV infection, are characterized by a tapered, atrophic encephalic trunk with preferential involvement of the pons (Figure 7), are commonly associated with more severe conditions and can be related to synergism between the reduction in the number of descending fibers and the direct effects of the virus^(34-43). Other abnormalities of the posterior fossa include cerebellar hypoplasia, which is usually diffuse and symmetric (Figure 8), occurring in 27–82% of cases, and an enlarged cisterna magna, the frequency of which increases in proportion to the severity of the infection, although there is no direct correlation between enlarged cisterna magna and the occurrence of cerebellar hypoplasia^(34-43).




Alteration of the white matter MRI signal secondary to a delay in myelination is seen in 88–100% of cases of congenital ZIKV infection. Confluence of the enlarged dural venous sinuses with heterogeneous material (Figure 1), which can correspond to a thrombus or a hematocrit effect due to dehydration with hemoconcentration, is seen in 28–53% of cases^{(34,35,38,41,42)}.

Currently, there are three severity spectra in congenital Zika syndrome⁽⁴¹⁾: with microcephaly at birth, presenting all of the abnormalities described in the literature and with a symmetric appearance; with postnatal microcephaly, the presentation of which is comparable to that of microcephaly at birth, minus the calcifications outside the cortical-subcortical junction and the agyria; and without microcephaly, which presents with calcifications restricted to the cortical-subcortical junction, areas of pachygyria, a delay in myelination, and slight ventricular enlargement, with an asymmetric appearance. In addition, as proposed by Aragão et al.⁽⁴¹⁾, the presence of polymicrogyria mainly in the frontal lobes is seen only in patients without microcephaly or with postnatal microcephaly.

Recently, spinal and nerve root changes have been described in congenital Zika syndrome, the severity of those changes presenting an apparent correlation with arthrogryposis, defined as contracture of two or more joints from birth⁽⁴²⁾. Visual inspection of T2-weighted MRI sequences in the sagittal and axial planes has revealed a significant reduction in the thickness of the entire spinal cord, accompanied by a significant reduction in the thickness of the anterior roots of the medullary cone, in patients with congenital Zika syndrome and arthrogryposis. However, patients who do not present such joint changes have been found to show a reduction in spinal thickness only in the dorsal region and only discrete tapering of the anterior roots of the medullary cone (Figure 9)⁽⁴²⁾. Clear involvement of the descending anterior medullary tracts, with apparent preservation of ascending posterior tracts, has also been seen, as reported by Mlakar et al.⁽²⁵⁾.




Aragão et al.⁽⁴²⁾ showed that arthrogryposis correlates with greater severity of brain damage, with a greater number of cerebral calcifications and a greater chance of infratentorial calcifications, as well as a greater chance of hypoplasia of the brainstem and cerebellum. In addition, all of the cases in which there was arthrogryposis have presented with pachygyria and an absence of polymicrogyria, which could indicate that congenital Zika syndrome with arthrogryposis occurs in the earlier stages of fetal development, because pachygyria results from failure of neuronal migration and of cortical organization between weeks 12 and 16 of gestation, whereas polymicrogyria occurs around week 20⁽⁴²⁾.


CONCLUSION

Fetal infection with ZIKV causes severe CNS developmental abnormalities. Although the neuroimaging findings are not pathognomonic, they can be suggestive of congenital Zika syndrome when the clinical and biochemical data are consistent with the diagnosis.

The main findings in congenital Zika syndrome are craniofacial disproportion with a microcephalic aspect, accompanied by calcifications (predominantly at the cortical-subcortical junction), malformations of cortical development, ventriculomegaly, and abnormalities in the formation of the corpus callosum. However, attention should be paid to the spectrum of potential presentations of congenital Zika syndrome, and the possibility of ZIKV involvement should not be ruled out when microcephaly is not present or when the neuroimaging findings are more subtle.


REFERENCES

1. Yadav S, Rawal G, Baxi M. Zika virus: an emergence of a new arbovirus. J Clin Diagn Res. 2016;10:DM01-3.

2. Abushouk AI, Negida A, Ahmed H. An updated review of Zika virus. J Clin Virol. 2016;84:53-8.

3. Atif M, Azeem M, Sarwar MR, et al. Zika virus disease: a current review of the literature. Infection. 2016;44:695-705.

4. Aziz H, Zia A, Anwer A, et al. Zika virus: global health challenge, threat and current situation. J Med Virol. 2017;89:943-51.

5. Blázquez AB, Saiz JC. Neurological manifestations of Zika virus infection. World J Virol. 2016;5:135-43.

6. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46:509-20.

7. Pinheiro TJ, Guimarães LF, Silva MTT, et al. Neurological manifestations of Chikungunya and Zika infections. Arq Neuropsiquiatr. 2016;74:937-43.

8. Younger DS. Epidemiology of Zika virus. Neurol Clin. 2016;34: 1049-56.

9. Niemeyer B, Niemeyer R, Borges R, et al. Acute disseminated encephalomyelitis following Zika virus infection. Eur Neurol. 2017; 77:45-6.

10. Hinckley AF, O''Leary DR, Hayes EB. Transmission of West Nile virus through human breast milk seems to be rare. Pediatrics. 2007; 119:666-71.

11. Fontes CAP, Santos AASMD, Marchiori E. Magnetic resonance imaging findings in Guillain-Barré syndrome caused by Zika virus infection. Neuroradiology. 2016;58:837-8.

12. Fauci AS, Morens DM. Zika virus in the Americas-yet another arbovirus threat. N Engl J Med. 2016;374:601-4.

13. Rasmussen SA, Jamieson DJ, Honein MA, et al. Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med. 2016;374:1981-7.

14. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360;2536-43.

15. Webster WS. Teratogen update: congenital rubella. Teratology. 1998;58:13-23.

16. Lammer EJ, Sever LE, Oakley GP Jr. Teratogen update: valproic acid. Teratology. 1987;35:465-73.

17. Shepard TH. "Proof" of human teratogenicity. Teratology. 1994;50: 97-8.

18. Oliveira WK, Cortez-Escalante J, Oliveira WTGH, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:242-7.

19. Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet. 2016;387:2125-32.

20. Teixeira MG, Costa MCN, Oliveira WK, et al. The epidemic of Zika virus-related microcephaly in Brazil: detection, control, etiology, and future scenarios. Am J Public Health. 2016;106:601-5.

21. Brasil P, Pereira JP Jr, Moreira ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med. 2016;375:2321-34.

22. Chan JF, Choi GK, Yip CC, et al. Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease. J Infect. 2016;72:507-24.

23. Costa F, Sarno M, Khouri R, et al. Emergence of congenital Zika syndrome: viewpoint from the front lines. Ann Intern Med. 2016; 164:689-91.

24. Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med. 2016;374:2142-51.

25. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374:951-8.

26. Bell TM, Field EJ, Narang HK. Zika virus infection of the central nervous system of mice. Arch Gesamte Virusforsch. 1971;35:183-93.

27. Dick GW. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg. 1952;46:521-34.

28. Miner JJ, Cao B, Govero J, et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell. 2016;165:1081-91.

29. Noronha L, Zanluca C, Azevedo ML, et al. Zika virus damages the human placental barrier and presents marked fetal neurotropism. Mem Inst Oswaldo Cruz. 2016;111:287-93.

30. Klase ZA, Khakhina S, Schneider AB, et al. Zika fetal neuropathogenesis: etiology of a viral syndrome. PLoS Negl Trop Dis. 2016;10:e0004877.

31. Wang J, Ling Feng. Zika virus infection and microcephaly: evidence for a causal link. Int J Environ Res Public Health. 2016;13. pii 1031.

32. Hajra A, Bandyopadhyay D, Heise L, et al. Zika and pregnancy: a comprehensive review. Am J Reprod Immunol. 2017;77. doi:10.1111/aji.12607. Epub 2016 Nov 25.

33. Ticconi C, Pietropolli A, Rezza G. Zika virus infection and pregnancy: what we do and do not know. Pathog Glob Health. 2016; 110:262-8.

34. Oliveira-Szejnfeld PS, Levine D, Melo ASO, et al. Congenital brain abnormalities and Zika virus: what the radiologist can expect to see prenatally and postnatally. Radiology. 2016;281:203-18.

35. Aragão MFV, van der Linden V, Brainer-Lima AM, et al. Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study. BMJ. 2016;353:i1901.

36. Hazin NA, Poretti A, Martelli CMT, et al. Computed tomographic findings in microcephaly associated with Zika virus. N Engl J Med. 2016;374:2193-5.

37. Mehrjardi MZ, Keshavarz E, Poretti A, et al. Neuroimaging findings of Zika virus infection: a review article. Jpn J Radiol. 2016;34:765-70.

38. Mehrjardi MZ, Poretti A, Huisman TAGM, et al. Neuroimaging findings of congenital Zika virus infection: a pictorial essay. Jpn J Radiol. 2017;35:89-94.

39. Moore CA, Staples JE, Dobyns WB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinics. JAMA Pediatr. 2017;171:288-95.

40. Werner H, Sodré D, Hygino C, et al. First trimester intrauterine Zika virus infection and brain pathology: prenatal and postnatal neuroimaging findings. Prenat Diagn. 2016;36:785-9.

41. Aragão MFVV, Holanda AC, Brainer-Lima AM, et al. Nonmicrocephalic infants with congenital Zika syndrome suspected only after neuroimaging evaluation compared with those with microcephaly at birth and postnatally: how large is the Zika virus "iceberg". AJNR Am J Neuroradiol. 2017;38:1427-34.

42. Aragão MFVV, Brainer-Lima AM, Holanda AC, et al. Spectrum of spinal cord, spinal root, and brain MRI abnormalities in congenital Zika syndrome with and without arthrogryposis. AJNR Am J Neuroradiol. 2017;38:1045-53.

43. van der Linden V, Pessoa A, Dobyns W, et al. Description of 13 infants born during October 2015-January 2016 with congenital Zika virus infection without microcephaly at birth - Brazil. MMWR Morb Mortal Wkly Rep. 2016;65:1343-8.










1. Masters Student, MD, Neuroradiologist at the Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, RJ, Brazil
2. Full Member of the Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR), MD, Neuroradiologist at the Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, RJ, Brazil
3. PhD, MD, Neuroradiologist, Head of the Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, RJ, Brazil
4. PhD, MD, Neuroradiologist at the Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, RJ, Brazil
5. Full Professor at the Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil

Mailing address:
Dr. Bruno Niemeyer de Freitas Ribeiro
Instituto Estadual do Cérebro Paulo Niemeyer – Departamento de Radiologia
Rua do Rezende, 156, Centro
Rio de Janeiro, RJ, Brazil, 22231-092
E-mail: bruno.niemeyer@hotmail.com

Received May 9, 2017.
Accepted after revision July 28, 2017.

Study conducted in the Radiology Department of the Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, RJ, Brazil.